Patents by Inventor Peter Thomas Lind

Peter Thomas Lind has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040116418
    Abstract: The present invention is directed to compounds, compositions and methods of inhibiting and treating HIV and related viruses, and methods for cocrystallizing reverse transcriptase in vitro, inhibition of the replication of HIV and related viruses thereof.
    Type: Application
    Filed: December 1, 2003
    Publication date: June 17, 2004
    Applicant: Medivir AB
    Inventors: Peter Thomas Lind, Rolf Noreen, John Michael Morin, Robert John Ternansky
  • Publication number: 20020132794
    Abstract: The present invention is directed to compounds, compositions and methods of inhibiting and treating HIV and related viruses, and methods for cocrystallizing reverse transcriptase in vitro, inhibition of the replication of HIV and related viruses thereof.
    Type: Application
    Filed: February 13, 2002
    Publication date: September 19, 2002
    Applicant: MEDIVIR AB
    Inventors: Peter Thomas Lind, Rolf Noreen, John Michael Morin, Robert John Ternansky
  • Patent number: 6376492
    Abstract: The present invention is directed to compounds, compositions and methods of inhibiting and treating HIV and related viruses, and methods for cocrystallizing reverse transcriptase in vitro, inhibition of the replication of HIV and related viruses thereof.
    Type: Grant
    Filed: May 9, 2000
    Date of Patent: April 23, 2002
    Assignee: Medivir AB
    Inventors: Peter Thomas Lind, Rolf Noréen, John Michael Morin, Robert John Ternansky
  • Patent number: 5849769
    Abstract: A method for treating HIV which comprises a compound of the formula ##STR1## wherein A is ##STR2## and Z.sub.i is O, Se, NR.sup.a or C(R.sup.a).sub.2, andZ.sub.ii is --O or (.dbd.O).sub.2 ;whereinR.sub.1, R.sub.2, R.sub.3, and R.sub.4 are as defined in the specification.
    Type: Grant
    Filed: May 3, 1996
    Date of Patent: December 15, 1998
    Assignee: Medivir AB
    Inventors: Peter Thomas Lind, Rolf Noreen, John Michael Morin, Robert John Ternansky